Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance
Recently, it has been suggested that metabolic syndrome should be considered a premorbid condition in younger individuals. We evaluated the prevalence of metabolic syndrome in Estonia and compared the characteristic profiles between morbid metabolic syndrome (previously established diabetes, hyperte...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2012/951672 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558118425329664 |
|---|---|
| author | Triin Eglit Tarvo Rajasalu Margus Lember |
| author_facet | Triin Eglit Tarvo Rajasalu Margus Lember |
| author_sort | Triin Eglit |
| collection | DOAJ |
| description | Recently, it has been suggested that metabolic syndrome should be considered a premorbid condition in younger individuals. We evaluated the prevalence of metabolic syndrome in Estonia and compared the characteristic profiles between morbid metabolic syndrome (previously established diabetes, hypertension, or dyslipidaemia) and premorbid metabolic syndrome subgroups. Our study was a cross-sectional, population-based sample of the general population in Estonia aged 20–74 years (n=495). Metabolic syndrome was diagnosed by National Cholesterol Education Program Adult Treatment Panel III criteria. Insulin resistance was estimated using the homeostasis model assessment (HOMA-IR). The crude and weighted prevalence of metabolic syndrome was 27.9% and 25.9%, respectively. Despite being significantly younger, the premorbid subgroup showed similar levels of insulin resistance as the morbid subgroup (mean HOMA-IR ± SD 2.73±1.8 versus 2.97±2.1, P=0.5). The most important attribute of metabolic syndrome is insulin resistance, which already characterises metabolic syndrome in the early stages of its metabolic abnormalities. |
| format | Article |
| id | doaj-art-9f446ef621fc49f3941618abb84b3d98 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-9f446ef621fc49f3941618abb84b3d982025-02-03T01:33:12ZengWileyInternational Journal of Endocrinology1687-83371687-83452012-01-01201210.1155/2012/951672951672Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin ResistanceTriin Eglit0Tarvo Rajasalu1Margus Lember2Department of Internal Medicine, University of Tartu, 6 L. Puusepa Street, 51014 Tartu, EstoniaDepartment of Internal Medicine, University of Tartu, 6 L. Puusepa Street, 51014 Tartu, EstoniaDepartment of Internal Medicine, University of Tartu, 6 L. Puusepa Street, 51014 Tartu, EstoniaRecently, it has been suggested that metabolic syndrome should be considered a premorbid condition in younger individuals. We evaluated the prevalence of metabolic syndrome in Estonia and compared the characteristic profiles between morbid metabolic syndrome (previously established diabetes, hypertension, or dyslipidaemia) and premorbid metabolic syndrome subgroups. Our study was a cross-sectional, population-based sample of the general population in Estonia aged 20–74 years (n=495). Metabolic syndrome was diagnosed by National Cholesterol Education Program Adult Treatment Panel III criteria. Insulin resistance was estimated using the homeostasis model assessment (HOMA-IR). The crude and weighted prevalence of metabolic syndrome was 27.9% and 25.9%, respectively. Despite being significantly younger, the premorbid subgroup showed similar levels of insulin resistance as the morbid subgroup (mean HOMA-IR ± SD 2.73±1.8 versus 2.97±2.1, P=0.5). The most important attribute of metabolic syndrome is insulin resistance, which already characterises metabolic syndrome in the early stages of its metabolic abnormalities.http://dx.doi.org/10.1155/2012/951672 |
| spellingShingle | Triin Eglit Tarvo Rajasalu Margus Lember Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance International Journal of Endocrinology |
| title | Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance |
| title_full | Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance |
| title_fullStr | Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance |
| title_full_unstemmed | Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance |
| title_short | Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance |
| title_sort | metabolic syndrome in estonia prevalence and associations with insulin resistance |
| url | http://dx.doi.org/10.1155/2012/951672 |
| work_keys_str_mv | AT triineglit metabolicsyndromeinestoniaprevalenceandassociationswithinsulinresistance AT tarvorajasalu metabolicsyndromeinestoniaprevalenceandassociationswithinsulinresistance AT marguslember metabolicsyndromeinestoniaprevalenceandassociationswithinsulinresistance |